Fig 1: Survival curve analysis of patients with different immune cell markers in gastric cancer. Association of (A) CD3+ regulatory T cell, (B) CD4+ T lymphocyte, (C) CD8+ cytotoxic lymphocyte, (D) CD80+ M1 macrophage, (E) CD19+ B lymphocyte and (F) CD206+ M2 macrophage cell infiltration with survival.
Supplier Page from Abcam for Anti-CD3 antibody [FN-18]